A simple and sensitive high-performance liquid chromatographic method for quantification of PXD101, a histone deacetylase inhibitor in human plasma
10.1097/FTD.0b013e31802c573e
Saved in:
Main Authors: | Zhang, N., Goh, B.C., Khoo, Y.M., Lee, H.S., Yeo, W. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27287 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
by: Yong, W.P., et al.
Published: (2014) -
Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents
by: Lin, H.-S., et al.
Published: (2014) -
The Roles of Histone Deacetylases 1 and 2 in Hepatocellular carcinoma
by: LEUNG HO WING, CAROL
Published: (2012) -
Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish
by: Farooq, M., et al.
Published: (2014) -
Histone deacetylase inhibitors: New hope for rheumatoid arthritis?
by: Choo, Q.Y., et al.
Published: (2014)